Applied Biosystems to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference on September 9

FOSTER CITY, Calif.--(BUSINESS WIRE)--Applied Biosystems Inc. (NYSE:ABI) announced today that it will participate in the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9. Dennis Winger, Chief Financial Officer, will provide a brief opening statement, followed by a question and answer session with investors and the firm’s financial analysts. The live webcast is scheduled to begin at 1:35 p.m. ET.

Interested parties may access the live webcast and replay by visiting the Investors section of the Applied Biosystems web site at http://ir.appliedbiosystems.com. It is suggested that interested parties access the webcast 15 minutes before the start of the live webcast. The webcast replay will be archived on the Presentations page of the Investors section of the website.

About Applied Biosystems

Applied Biosystems Inc. (formerly known as Applera Corporation) is a global leader in the development and marketing of instrument-based systems, consumables, software, and services for academic research, the life science industry and commercial markets. Driven by its employees' belief in the power of science to improve the human condition, the company commercializes innovative technology solutions for DNA, RNA, protein and small molecule analysis. Customers across the disciplines of academic and clinical research, pharmaceutical research and manufacturing, forensic DNA analysis, and agricultural biotechnology use the company’s tools and services to accelerate scientific discovery, improve processes related to drug discovery and development, detect potentially pathogenic microorganisms, and identify individuals based on DNA sources. Applied Biosystems has a comprehensive service and field applications support team for a global installed base of high-performance genetic and protein analysis solutions. Applied Biosystems Inc. is headquartered in Norwalk, CT. On June 12, 2008, Applera Corporation and Invitrogen Corporation (NASDAQ:IVGN) announced that their Boards of Directors had approved a definitive merger agreement under which Invitrogen will acquire all of the outstanding shares of Applied Biosystems stock. The merger is subject to customary closing conditions and is targeted to close in the fall of 2008. Further information regarding the merger will be provided in a joint proxy statement/prospectus to be mailed to shareholders of both companies. Investors and security holders are urged to read this document it in its entirety because it will contain important information about the companies and the proposed transaction. Information about Applied Biosystems, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.appliedbiosystems.com. All information in this news release is as of the date of the release, and Applied Biosystems does not undertake any duty to update this information unless required by law.

©Copyright 2008. Applied Biosystems Inc. All rights reserved. Applera, Applied Biosystems, and AB (Design) are registered trademarks of Applied Biosystems Inc. or its subsidiaries in the U.S. and/or certain other countries.